JHJiahua He

Jiahua He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiahua He has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Danrui Bu

    College of Veterinary Medicine, Beijing University of Agriculture, No. 7 Beinong Road, Changping, Beijing 102206, China

    1 shared publication
  • Tingting Wan

    College of Veterinary Medicine, Beijing University of Agriculture, No. 7 Beinong Road, Changping, Beijing 102206, China

    1 shared publication
  • Xiaoye Liu

    Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, No. 7 Beinong Road, Changping, Beijing 102206, China

    1 shared publication
  • Yan Lu

    National Experimental Teaching Demonstration Center for Animals, Beijing University of Agriculture, Beijing 102206, China

    1 shared publication
  • Yuting Zhang

    College of Veterinary Medicine, Beijing University of Agriculture, No. 7 Beinong Road, Changping, Beijing 102206, China

    1 shared publication
  • Zhao Liu

    College of Veterinary Medicine, Beijing University of Agriculture, No. 7 Beinong Road, Changping, Beijing 102206, China

    1 shared publication

Latest Publications

  • Open Access

    Genomic Characterization of Multidrug-Resistant Escherichia coli from Bovine Mastitis and Therapeutic Evaluation of Thanatin Combined with Gallium Nitrate

    by Zhuo Li, Yuting Zhang, Danrui Bu, Zhao Liu, Jiahua He, Tingting Wan, Yan Lu, Xiaoye Liu

    Bovine mastitis caused by multidrug-resistant (MDR) Escherichia coli remains a major challenge in the dairy industry due to recurrent infection, excessive lipopolysaccharide (LPS) release, and persistent mammary inflammation. Whole-genome sequencing (WGS) revealed that the clinical isolate was resistant to seven classes of antibiotics and exhibited a marked enrichment of iron uptake systems, which accounted for 27.14% of the 140 virulence genes identified. Upon this, we developed a targeted combination therapy using the iron mimetic gallium nitrate and the antimicrobial peptide thanatin (Tn). A rat model of mastitis was established to evaluate the in vivo therapeutic efficacy of the Tn-gallium nitrate combination. Our results demonstrated that the combination of gallium nitrate and Tn exerted a potent enhanced therapeutic effect in the rat mastitis model. This regimen significantly inhibited bacterial proliferation, neutralized endotoxin activity, and downregulated the expression of pro-inflammatory cytokines. Histopathological evaluation confirmed that the combination therapy effectively protected the alveolar structure and alleviated tissue damage, with a protective effect superior to that of ceftiofur (CEF), the first-line clinical drug. Collectively, our findings demonstrate the therapeutic potential of the combination of thanatin and gallium nitrate in a rat model of mastitis and provide experimental evidence supporting the development of a novel non-antibiotic therapeutic strategy for bovine mastitis caused by multidrug-resistant E. coli.